Targeted resequencing of 30 genes improves the detection of deleterious mutations in South Indian women with breast and/or ovarian cancers

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 13, 2015, Pages 5211-5217

  Rajkumar, Thangarajan ^a   Meenakumari, Balaiah ^a   Mani, Samson ^a   Sridevi, Veluswami ^a   Sundersingh, Shirley ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

ATM; BRCA1 BRCA2 RAD50 RAD52; Deleterious mutations; Targeted resequencing; TP53BP1

Indexed keywords

BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN; BRCA2 PROTEIN, HUMAN; PROTEIN P53; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; BIOLOGY; BREAST NEOPLASMS; CANCER STAGING; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MIDDLE AGED; MORTALITY; MUTATION; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

ADULT; BIOMARKERS, TUMOR; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84939445966     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.13.5211     Document Type: Article

References (38)

1. Bar-Sade RB, Kruglikova A, Modan B, et al (1998). The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Hum Mol Genet, 7, 801-5.
2. Bell DW, Wahrer DC, Kang DH, et al (1999). Common nonsense mutations in RAD52. Cancer Res, 59, 3883-8.
3. Bogdanova N, Feshchenko S, Schurmann P, et al (2008). Nijimegen breakage syndrome mutations and breast cancer. Int J Cancer, 122, 802-806.
4. Braggio E, Egan JB, Fonseca R, Stewart AK (2013). Lessons from next-generation sequencing analysis in haematological malignancies. Blood Cancer J, [Epub ahead of print].
5. Cao YW, Fu XG, Wan GX, et al (2014). BRCA1 gene exon 11 mutations in Uighur and Han women with early-onset sporadic breast cancer in the northwest region of China. Asian Pac J Cancer Prev, 15, 4513-8.
6. Cox A, Dunning AM, Garcia-Closas M, et al (2007). Breast cancer association consortium. a common coding variant in CASP8 is associated with breast cancer risk. Nat Genet, 39, 352-8.
7. De la Torre C, Pincheira J, Lopez-Saez JF (2003). Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand break. Histol Histopathol, 18, 225-43.
8. Easton DF, Pooley KA, Dunning AM, et al (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-93.
9. Ferlay J, Soerjomataram I, Ervik M, et al (2013). Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: international agency for research on cancer. GLOBOCAN 2012 v1.0. Available from: http://globocan.iarc.fr.
10. Han J, Hankinson SE, De Vivo I, Colditz GA, Hunter DJ (2002). No association between a stop codon polymorphism in RAD52 and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1138-9.
11. Hearle N, Schumacher V, Menko FH, et al (2006). Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res, 12, 3209-15.
12. Kooshyar MM, Nassiri M, Mahdavi M, Doosti M, Parizadeh A (2013). Identification of germline BRCA1 mutations among breast cancer families in northeastern Iran. Asian Pac J Cancer Prev, 14, 4339-45.
13. Laudico A, Redaniel MT, Mirasol-Lumague MR, et al (2009). Epidemiology and clinicopathology of breast cancer in metro Manilla and Rizal province, Philippines. Asian Pac J Cancer Prev, 10, 167-72.
14. Lee JH, Mand MR, Deshpande RA, et al (2013). Ataxia telangiectasia-mutated (ATM) is regulated byATP-driven conformational changes in the mre11/Rad50/Nbs1 (MRN) complex. J Biol Chem, 288, 12840-51.
15. Luo H, Li Z, Qing Y, et al (2014). Single nucleotide polymorphisms of DNA base-excision repair genes (APE1, OGG1 and XRCC1) associated with breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 15, 1133-40.
16. Mahdi KM, Nassiri MR, Nasiri K (2013). Hereditary genes and SNPs associated with breast cancer. Asian Pac J Cancer Prev, 14, 3403-9.
17. Majeed W, Aslam B, Javed I, et al (2014). Breast cancer: major risk factors and recent developments in treatment. Asian Pac J Cancer Prev, 15, 3353-8.
18. Masciari S, Larsson N, Senz J, et al (2007). Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet, 44, 7.
19. Meldrum C, Doyle MA, Tothill RW (2011). Next generation sequencing for cancer diagnostics: a practical perspective. Clin Biochem Rev, 32, 177-95.
20. Nichols KE1, Malkin D, Garber JE, Fraumeni JF Jr, Li FP (2001). Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev, 10, 83-7.
21. Park MS, Ludwig DL, Stigger E, Lee SH (1996). Physical interaction between human RAD52 and RPA is required for homologous recombination in mammalian cells. J Biol Chem, 271, 18996-9000.
22. Petitjean A, Mathe E, Kato S, et al (2007). Impact of mutant p53 functional properties on TP53 mutation patterns and tumour phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat, 28, 622-9.
23. Rajkumar T, Soumittra N, Nancy NK, et al (2003). BRCA1, BRCA2 and CHEK2 (1100 del C) germline mutations in hereditary breast and ovarian cancer families in South India. Asian Pac J Cancer Prev, 4, 203-8.
24. Ripperger T, Gadzicki D, Meindl A, Schlegelberger B (2009). Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet, 17, 722-31.
25. Saal LH, Gruvberger-Saal SK, Persson C, et al (2008). Recurrent gross mutations of the PTEN tumour suppressor gene in breast cancers with deficient DSB repair. Nat Genet, 40, 102-7.
26. Samson M, Swaminathan R, Rama R, et al (2007). Role of GSTM1 (Null/Present), GSTP1 (Ile105Val) and P53 (Arg72Pro) genetic polymorphisms and the risk of breast cancer-a case control study from South India. Asian Pac J Cancer Prev, 8, 253-7.
27. Samson M, Swaminathan R, Rama R, et al (2009). CYP17 (T-34C), CYP19 (Trp39Arg), and FGFR2 (C-906T) polymorphisms and the risk of breast cancer in South Indian women population. Asian Pac J Cancer Prev, 10, 111-4.
28. Schrader KA, Masciari S, Boyd N, et al (2008). Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer, 7, 73-82.
29. Scott RJ, McPhillips M, Meldrum CJ, et al (2001). Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet, 68, 118-27.
30. Sharma S, Sambyal V, Guleria K, et al (2014). P53 polymorphisms in sporadic North Indian breast cancer patients. Asian Pac J Cancer Prev, 15, 6871-9.
31. Shin A, Lee KM, Ahn B, et al (2008). Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev, 9, 501-5.
32. Soumittra N, Meenakumari B, Parija T, et al (2009). Molecular genetics analysis of hereditary breast and ovarian cancer patients in India. Hered Cancer Clin Pract, 7, 13.
33. Tinat J, Bougeard G, Baert-Desurmont S, et al (2009). 2009 version of the Chompret criteria for Li Fraumeni syndrome. JCO, 27, 108-9.
34. Tong D, Volm T, Eberhardt E, et al (2003). Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients. Oncol Rep, 10, 1551-3.
35. Vasen HF, Morreau H, Nortier JW (2001). Is breast cancer part of the tumour spectrum of hereditary nonpolyposis colorectal cancer? Am J Hum Genet, 68, 1533-5.
36. Vaidyanathan K, Lakhotia S, Ravishankar HM, et al (2009). BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identifification of four novel mutations and high-frequency occurrence of 185delAG mutation. J Biosci, 34, 415-22.
37. Walsh T, Lee MK, Casadei S, et al (2010). Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing. Proc Natl Acad Sci U S A, 107, 12629-33.
38. Yang Y, Zhang F, Wang Y, Liu SC (2012). CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls. Asian Pac J Cancer Prev, 13, 3501-5.